Melius Pharma AB
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- Private
- Established
- 2021-08-01
- Employees
- 1
- Market Cap
- -
- Website
- https://www.meliuspharma.com
Efficacy and Safety of ME-015 (Suplatast Tosilate) in Cough Related to Idiopathic Pulmonary Fibrosis (COSMIC-IPF)
Phase 2
Active, not recruiting
- Conditions
- Idiopathic Pulmonary FibrosisFibrotic Lung DiseaseCoughIPFChronic CoughCoughing
- Interventions
- Drug: ME-015 (Suplatast Tosilate)Other: Identical placebo
- First Posted Date
- 2023-08-09
- Last Posted Date
- 2025-04-09
- Lead Sponsor
- Melius Pharma AB
- Target Recruit Count
- 40
- Registration Number
- NCT05983471
- Locations
- 🇮🇳
Aditya Multi Specialty Hospital, Guntur, Andhra Pradesh, India
🇮🇳KLE's Dr Prabhakar Kore Hospital & Medical Research Centre, Belgaum, Karnataka, India
🇮🇳ACE Hospital and Research Centre, Pune, Maharashtra, India
© Copyright 2025. All Rights Reserved by MedPath